An experimental treatment produced „cancer-free” status for a 51 old woman in the UK


Miracles happen and scientists work to make it easier. Jasmin David, 51, a woman who lives in Fallowfield, diagnosed with an aggressive form of breast cancer, was given one year to live after the cancer had spread to her lungs, chest bone and lymph nodes but is now cancer-free. No chemotherapy, mastectomy and radiotherapy helped but paricipating in a clinical trial at at the National Institute for Health and Care Research (NIHR) Manchester Clinical Research Facility (CRF) at Christie NHS Foundation Trust in UK where she was given experimental medicine combined with immunotherapy drug Atezolizumab. Doctors have told her she is now showing no evidence of the disease. After two years on the trial the result is LIFE. There were “horrible” side effects including headaches and high temperatures when the treatment started. “There is a change in my life after returning from India to see family in April and I have decided to take early retirement and to live my life in gratitude to God and to medical science,” she declared. To be sure, she will continue taking the treatment until December 2023.


Prof Fiona Thistlethwaite, medical oncologist and clinical director at The Christie, who is leading the trial, said: “It is fantastic for everyone when someone responds as well to treatment as Jasmin has.” „At The Christie, we are continually testing new drugs and therapies to see if they can benefit more people,”she added. Atezolizumab is an immunotherapy drug administered intravenously. It was combined with an experimental drug.